- Home
- COCH vs LVTX Comparison
COCH vs LVTX Comparison
Compare COCH & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- LVTX
- Stock Information
- Founded
- COCH 1995
- LVTX 2016
- Country
- COCH United States
- LVTX Netherlands
- Employees
- COCH N/A
- LVTX N/A
- Industry
- COCH Blank Checks
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- COCH Finance
- LVTX Health Care
- Exchange
- COCH Nasdaq
- LVTX Nasdaq
- Market Cap
- COCH 31.6M
- LVTX 33.9M
- IPO Year
- COCH N/A
- LVTX 2021
- Fundamental
- Price
- COCH $1.48
- LVTX $1.32
- Analyst Decision
- COCH Strong Buy
- LVTX Hold
- Analyst Count
- COCH 2
- LVTX 3
- Target Price
- COCH $9.25
- LVTX $1.75
- AVG Volume (30 Days)
- COCH 19.7K
- LVTX 34.5K
- Earning Date
- COCH 08-11-2025
- LVTX 08-19-2025
- Dividend Yield
- COCH N/A
- LVTX N/A
- EPS Growth
- COCH N/A
- LVTX N/A
- EPS
- COCH N/A
- LVTX N/A
- Revenue
- COCH $212,000.00
- LVTX $4,990,000.00
- Revenue This Year
- COCH $8.04
- LVTX N/A
- Revenue Next Year
- COCH $15.39
- LVTX N/A
- P/E Ratio
- COCH N/A
- LVTX N/A
- Revenue Growth
- COCH N/A
- LVTX N/A
- 52 Week Low
- COCH $1.21
- LVTX $0.85
- 52 Week High
- COCH $3.99
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- COCH 51.56
- LVTX 49.61
- Support Level
- COCH $1.36
- LVTX $1.28
- Resistance Level
- COCH $1.47
- LVTX $1.38
- Average True Range (ATR)
- COCH 0.10
- LVTX 0.05
- MACD
- COCH 0.00
- LVTX -0.00
- Stochastic Oscillator
- COCH 47.45
- LVTX 26.92
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.